Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Azn save search
Gene Therapy Company Genprex, Inc. (NASDAQ: GNPX) Receives Fast Track Designation From The FDA For Its Small Cell Lung Cancer Drug Candidate
Published: 2023-07-11 (Crawled : 14:00) - biospace.com/
GNPX | $2.32 7.26% 6.77% 30K
|
Health Technology
|
| O: 1.25%
H: 3.41%
C: -1.43%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.28%
H: 0.25%
C: -0.23%
fda lung drug candidate cancer cell designation therapy fast track designation
Multiple Myeloma Drugs Market to grow by USD 6,419.94 million from 2022 to 2027|Growing incidence of multiple myeloma boosts the market growth - Technavio
Published: 2023-07-10 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: -3.53%
H: 0.0%
C: 0.0%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.23%
H: 0.4%
C: 0.4%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 0.18%
H: 0.7%
C: 0.62%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: -0.36%
H: 1.31%
C: 1.17%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: 0.0%
H: 0.62%
C: 0.45%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.28%
H: 0.25%
C: -0.23%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: -0.4%
H: 0.78%
C: 0.01%
growth market
Acute Ischemic Stroke Therapeutics Market to grow by USD 1,524.49 million from 2022 to 2027|Rising prevalence of disease boosts the market - Technavio
Published: 2023-07-10 (Crawled : 19:00) - prnewswire.com
MDT | $81.29 0.89% 0.0% 5.2M
|
Health Technology
|
| O: -0.15%
H: 1.17%
C: 1.12%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
BIIB | $193.18 -0.48% -0.48% 1.4M
|
Health Technology
|
| O: -0.56%
H: 0.19%
C: -0.06%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.28%
H: 0.25%
C: -0.23%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: -0.4%
H: 0.78%
C: 0.01%
disease stroke therapeutics market
Global Respiratory Inhalers Strategic Business Report 2023: Rise in Air Pollution Levels and Consequent Increase in Respiratory Diseases Trigger the Demand for Inhalers
Published: 2023-07-08 (Crawled : 04:20) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
| Email alert
Add to watchlist
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
| Email alert
Add to watchlist
PHG | News | $21.01 1.94% 0.0% 2M
|
Health Technology
| Email alert
Add to watchlist
air report business respiratory global
Digital Dose Inhalers Global Market is Projected to Reach $7.2 Billion by 2030: Respiratory Care Domain Perfectly Ripe for Adoption of Digital Devices
Published: 2023-07-08 (Crawled : 04:20) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
| Email alert
Add to watchlist
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
| Email alert
Add to watchlist
ATR | $140.15 -0.12% 0.0% 420K
|
Process Industries
| Email alert
Add to watchlist
PHG | News | $21.01 1.94% 0.0% 2M
|
Health Technology
| Email alert
Add to watchlist
respiratory reach care global market
Global Seasonal Influenza Vaccine Market Research 2023-2029: Competitive Developments, Strategies, Mergers and Acquisitions and New Product Developments
Published: 2023-07-07 (Crawled : 02:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: -2.33%
H: 1.44%
C: -1.24%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: -0.84%
H: 1.54%
C: 0.05%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.12%
H: 0.28%
C: -0.73%
acquisitions vaccine influenza research global market
Precision Medicine Market size to grow by USD 54.07 billion from 2022 to 2027|Growing prevalence of chronic diseases to boost market growth - Technavio
Published: 2023-07-04 (Crawled : 12:00) - prnewswire.com
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $95.11 6.88% 490
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
| Email alert
Add to watchlist
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
| Email alert
Add to watchlist
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
| Email alert
Add to watchlist
TMO | News | $574.59 4.78% -1.12% 2.5M
|
Health Technology
| Email alert
Add to watchlist
growth market
Datopotamab Deruxtecan Met Dual Primary Endpoint of Progression-Free Survival in Patients with Advanced Non Small Cell Lung Cancer in TROPION-Lung01 Phase 3 Trial
Published: 2023-07-03 (Crawled : 08:00) - biospace.com/
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -6.26%
H: 0.33%
C: -2.74%
lung cancer cell trial
Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published: 2023-06-30 (Crawled : 23:00) - prnewswire.com
ALKS | $24.26 0.79% 0.78% 1.2M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
| Email alert
Add to watchlist
NBIX | News M | $140.11 4.83% 4.6% 1.6M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
UCBJY | $64.93 -4.38% 6.2K
|
Manufacturing
| Email alert
Add to watchlist
UCBJF | $128.725 -39.66% 750
|
Health Technology
| Email alert
Add to watchlist
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
| Email alert
Add to watchlist
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
| Email alert
Add to watchlist
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $95.11 6.88% 490
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
| Email alert
Add to watchlist
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
| Email alert
Add to watchlist
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
| Email alert
Add to watchlist
report business life global therapeutics
Rallybio Announces Succession Plan; Appoints Stephen Uden, M.D., as Chief Executive Officer, Effective August 1, 2023
Published: 2023-06-29 (Crawled : 12:20) - biospace.com/
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: 1.06%
H: 0.72%
C: 0.72%
RLYB | News | $1.84 3.96% 3.8% 240K
|
|
| O: -0.34%
H: 4.41%
C: -5.25%
NVO | News | $128.64 2.7% -0.07% 3.7M
|
Health Technology
|
| O: -1.19%
H: 1.41%
C: 1.36%
CRL | News | $240.13 3.26% 0.0% 610K
|
Commercial Services
|
| O: 0.09%
H: 1.73%
C: 1.58%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.83%
H: 0.89%
C: 0.68%
Urica Therapeutics Announces Topline Data from the Phase 1 Clinical Trial Evaluating Dotinurad in Healthy Volunteers in the United States
Published: 2023-06-29 (Crawled : 12:20) - globenewswire.com
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: 1.06%
H: 0.72%
C: 0.72%
FBIO | $1.79 2.29% 2.23% 190K
|
Health Technology
|
| O: 0.0%
H: 7.55%
C: 7.55%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.83%
H: 0.89%
C: 0.68%
topline trial therapeutics
Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Report 2023: Increasing Prevalence of Lung Disease Drives Growth
Published: 2023-06-28 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: 1.75%
H: 0.06%
C: 0.06%
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: 1.06%
H: 0.72%
C: 0.72%
ALPMY | News | $9.53 -1.11% 690K
|
Manufacturing
|
| O: -1.98%
H: 0.0%
C: -0.47%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.17%
H: 0.85%
C: 0.76%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: -1.21%
H: 1.17%
C: 0.91%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: -0.54%
H: 0.78%
C: 0.59%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -1.86%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.83%
H: 0.89%
C: 0.68%
lung disease report treatment global growth market
Genprex Receives U.S. FDA Fast Track Designation for REQORSA® Immunogene Therapy in Combination with Tecentriq® for the Treatment of Small Cell Lung Cancer
Published: 2023-06-28 (Crawled : 14:00) - biospace.com/
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: -2.36%
GNPX | $2.32 7.26% 6.77% 30K
|
Health Technology
|
| O: 14.85%
H: 1.18%
C: -7.27%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.29%
H: 0.13%
C: -0.7%
reqorsa fda lung cancer cell treatment designation therapy fast track designation
AstraZeneca announces $400 million investment in reforestation and biodiversity in support of climate action and human health
Published: 2023-06-28 (Crawled : 08:00) - biospace.com/
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: -2.36%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.29%
H: 0.13%
C: -0.7%
health
Global Cancer Therapies Strategic Business Report 2023: Industry Focuses on New Approaches to Treat Cancer
Published: 2023-06-27 (Crawled : 01:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: -0.95%
H: 0.19%
C: -0.32%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.19%
H: 0.11%
C: -1.46%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -0.01%
H: 0.16%
C: -0.32%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.03%
H: 0.12%
C: -0.24%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: -0.91%
H: 0.56%
C: -0.5%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 2.15%
H: 1.18%
C: 0.43%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: -0.06%
H: 0.46%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.21%
H: 0.42%
C: 0.13%
report business cancer treat global
Autolus Therapeutics strengthens its Board with the appointment of Dr. Robert Iannone as a Non-Executive Director
Published: 2023-06-20 (Crawled : 11:00) - globenewswire.com
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: -0.17%
H: 0.0%
C: 0.0%
JAZZ | $109.685 0.79% 0.78% 380K
|
Health Technology
|
| O: -0.58%
H: 0.81%
C: 0.08%
AUTL | $4.5 -1.32% -1.33% 1.7M
|
Health Technology
|
| O: 1.73%
H: 4.08%
C: 1.02%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.96%
H: 0.17%
C: -0.74%
therapeutics
Helocyte Announces $3.22 Million Grant from the National Cancer Institute for Triplex Phase 2 Clinical Trial Program
Published: 2023-06-15 (Crawled : 12:20) - globenewswire.com
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: 0.97%
H: 0.64%
C: 0.64%
FBIO | $1.79 2.29% 2.23% 190K
|
Health Technology
|
| O: 2.42%
H: 10.78%
C: 7.94%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: 1.68%
H: 1.0%
C: 0.84%
cancer grant program trial phase 2
Global Opioid Induced Constipation Markets to 2030: Revenues, Trends, Competitive Assessment & Intelligence
Published: 2023-06-09 (Crawled : 22:00) - prnewswire.com
BHC | $8.53 0.95% 0.0% 4M
|
Health Technology
| Email alert
Add to watchlist
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
| Email alert
Add to watchlist
IRWD | $8.305 3.04% 2.95% 2.1M
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
| Email alert
Add to watchlist
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
| Email alert
Add to watchlist
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
| Email alert
Add to watchlist
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
| Email alert
Add to watchlist
VTRS | News A | $11.36 0.98% 0.97% 4.7M
|
Health Technology
| Email alert
Add to watchlist
opioid global
Global Peptide Therapeutics Market Report 2023: Increasing Prevalence of Cancer and Metabolic Disorders Drives Growth
Published: 2023-06-08 (Crawled : 02:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: 0.07%
H: 0.0%
C: -1.7%
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: -0.62%
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: -0.62%
H: 0.88%
C: 0.81%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 1.26%
H: 1.08%
C: 0.91%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 0.41%
H: 0.68%
C: 0.64%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: -0.11%
H: 2.66%
C: 2.24%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: 0.28%
H: 0.42%
C: -0.05%
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: 0.39%
H: 0.15%
C: -0.79%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.23%
H: 1.83%
C: 1.52%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.0%
H: 0.28%
C: -0.23%
metabolic report cancer global therapeutics growth market
Precision Medicine Market size to grow by USD 54.07 billion from 2022 to 2027, The growing prevalence of chronic diseases to boost market growth - Technavio
Published: 2023-06-06 (Crawled : 04:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: 1.18%
H: 0.37%
C: -0.99%
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 1.88%
H: 0.0%
C: -1.15%
TMO | News | $574.59 4.78% -1.12% 2.5M
|
Health Technology
|
| O: 0.66%
H: 0.23%
C: -1.1%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.91%
H: 0.1%
C: -0.61%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.45%
H: 0.05%
C: -1.48%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.94%
H: 0.27%
C: 0.02%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: 0.79%
H: 0.27%
C: -0.52%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.54%
H: 0.04%
C: -0.83%
growing growth market
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.